FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial Read more
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement Read more
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders Read more
Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema Read more
Leads Biolabs Secures Orphan Drug Designation from US FDA for LBL-034, a Novel Anti-GPRC5D/CD3 Bispecific Antibody Targeting Multiple Myeloma Read more
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Read more
Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama Read more
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk Read more
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI Read more